<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33465">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02670967</url>
  </required_header>
  <id_info>
    <org_study_id>FIberBPMeta</org_study_id>
    <nct_id>NCT02670967</nct_id>
  </id_info>
  <brief_title>Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials</brief_title>
  <official_title>Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study conducted a meta-analysis of 22 randomly controlled trials to assess the
      effects of soluble fiber intake on blood pressure in human subjects.

      Using the Cochrane Handbook for Systematic Reviews of Intervention, a systematic review and
      meta-analysis was conducted. Information regarding study methods, characteristics, mean BP
      and standard deviations were extracted The data from each study were pooled using a random
      effects model to estimate the effects of soluble fiber consumption on blood pressure.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Blood Pressure</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soluble Fibre</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy, hypertensive, hypercholesterolaemic, diabetic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Randomized Controlled Trials

          -  Parallel or Crossover Design

          -  Duration: &gt;3 weeks

          -  Human trials

          -  Viscous (soluble) fiber

          -  Viable endpoint data

          -  Articles published in English

        Exclusion Criteria:

          -  Non-human

          -  Non-randomized

          -  Lack of control

          -  Less than 4 weeks in duration

          -  No viable endpoint data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir Vuksan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kashif Khan, BSc</last_name>
    <role>Study Director</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2T2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>February 1, 2016</lastchanged_date>
  <firstreceived_date>August 11, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
